ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-36L13852
Home | Market Reports | Science| Biological Sciences
Global Chimeric Antigen Receptor CAR T Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2025

Code: QYRE-Auto-36L13852
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Gilead Sciences
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Bluebird bio
Bristol–Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Mustang Bio
CELLECTIS
Allogene Therapeutics
Celyad

Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size

The global market for Chimeric Antigen Receptor (CAR) T-Cell Therapy was valued at US$ 5168 million in the year 2024 and is projected to reach a revised size of US$ 30680 million by 2031, growing at a CAGR of 29.4% during the forecast period.

Chimeric Antigen Receptor (CAR) T-Cell Therapy Market

Chimeric Antigen Receptor (CAR) T-Cell Therapy Market

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient"s T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor (CAR) T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor (CAR) T-Cell Therapy.
The Chimeric Antigen Receptor (CAR) T-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chimeric Antigen Receptor (CAR) T-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Report

Report Metric Details
Report Name Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
Accounted market size in year US$ 5168 million
Forecasted market size in 2031 US$ 30680 million
CAGR 29.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • CD19-targeted
  • BCMA-targeted
Segment by Application
  • Lymphoma
  • Multiple Myeloma
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics, Sorrento Therapeutics, Mustang Bio, Bluebird Bio, Cellectis, Allogene Therapeutics, Celyad
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chimeric Antigen Receptor (CAR) T-Cell Therapy Market growing?

Ans: The Chimeric Antigen Receptor (CAR) T-Cell Therapy Market witnessing a CAGR of 29.4% during the forecast period 2025-2031.

What is the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market size in 2031?

Ans: The Chimeric Antigen Receptor (CAR) T-Cell Therapy Market size in 2031 will be US$ 30680 million.

Who are the main players in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market report?

Ans: The main players in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics, Sorrento Therapeutics, Mustang Bio, Bluebird Bio, Cellectis, Allogene Therapeutics, Celyad

What are the Application segmentation covered in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market report?

Ans: The Applications covered in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market report are Lymphoma, Multiple Myeloma

What are the Type segmentation covered in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market report?

Ans: The Types covered in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market report are CD19-targeted, BCMA-targeted

Recommended Reports

CAR-T Cell Therapy

T Cell Immunotherapy

Haematological Cancer

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Perspective (2020-2031)
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Growth Trends by Region
2.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in 2024
3.5 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy Head office and Area Served
3.6 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Product and Application
3.7 Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (2020-2031)
6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025)
6.4 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (2020-2031)
7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (2020-2031)
9.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.1.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.2.4 Gilead Sciences Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.4.4 J & J Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.6.4 FOSUNKite Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Details
11.7.2 CARsgen Therapeutics Business Overview
11.7.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.7.4 CARsgen Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.7.5 CARsgen Therapeutics Recent Development
11.8 Autolus Therapeutics
11.8.1 Autolus Therapeutics Company Details
11.8.2 Autolus Therapeutics Business Overview
11.8.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.8.4 Autolus Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.8.5 Autolus Therapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Details
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Mustang Bio
11.10.1 Mustang Bio Company Details
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.10.4 Mustang Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.10.5 Mustang Bio Recent Development
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Details
11.11.2 Bluebird Bio Business Overview
11.11.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.11.4 Bluebird Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.11.5 Bluebird Bio Recent Development
11.12 Cellectis
11.12.1 Cellectis Company Details
11.12.2 Cellectis Business Overview
11.12.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.12.4 Cellectis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.12.5 Cellectis Recent Development
11.13 Allogene Therapeutics
11.13.1 Allogene Therapeutics Company Details
11.13.2 Allogene Therapeutics Business Overview
11.13.3 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.13.4 Allogene Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.13.5 Allogene Therapeutics Recent Development
11.14 Celyad
11.14.1 Celyad Company Details
11.14.2 Celyad Business Overview
11.14.3 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction
11.14.4 Celyad Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
11.14.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Gilead Sciences
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Bluebird bio
Bristol–Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Mustang Bio
CELLECTIS
Allogene Therapeutics
Celyad
List of Tables
 Table 1. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of CD19-targeted
 Table 3. Key Players of BCMA-targeted
 Table 4. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Region (2020-2025)
 Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Region (2026-2031)
 Table 10. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Trends
 Table 11. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers
 Table 12. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Challenges
 Table 13. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Restraints
 Table 14. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy as of 2024)
 Table 17. Ranking of Global Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Product and Application
 Table 21. Global Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Novartis Company Details
 Table 47. Novartis Business Overview
 Table 48. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 49. Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 50. Novartis Recent Development
 Table 51. Gilead Sciences Company Details
 Table 52. Gilead Sciences Business Overview
 Table 53. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 54. Gilead Sciences Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 55. Gilead Sciences Recent Development
 Table 56. Bristol-Myers Squibb Company Details
 Table 57. Bristol-Myers Squibb Business Overview
 Table 58. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 59. Bristol-Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 60. Bristol-Myers Squibb Recent Development
 Table 61. J & J Company Details
 Table 62. J & J Business Overview
 Table 63. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 64. J & J Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 65. J & J Recent Development
 Table 66. JW Therapeutics Company Details
 Table 67. JW Therapeutics Business Overview
 Table 68. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 69. JW Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 70. JW Therapeutics Recent Development
 Table 71. FOSUNKite Company Details
 Table 72. FOSUNKite Business Overview
 Table 73. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 74. FOSUNKite Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 75. FOSUNKite Recent Development
 Table 76. CARsgen Therapeutics Company Details
 Table 77. CARsgen Therapeutics Business Overview
 Table 78. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 79. CARsgen Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 80. CARsgen Therapeutics Recent Development
 Table 81. Autolus Therapeutics Company Details
 Table 82. Autolus Therapeutics Business Overview
 Table 83. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 84. Autolus Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 85. Autolus Therapeutics Recent Development
 Table 86. Sorrento Therapeutics Company Details
 Table 87. Sorrento Therapeutics Business Overview
 Table 88. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 89. Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 90. Sorrento Therapeutics Recent Development
 Table 91. Mustang Bio Company Details
 Table 92. Mustang Bio Business Overview
 Table 93. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 94. Mustang Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 95. Mustang Bio Recent Development
 Table 96. Bluebird Bio Company Details
 Table 97. Bluebird Bio Business Overview
 Table 98. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 99. Bluebird Bio Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 100. Bluebird Bio Recent Development
 Table 101. Cellectis Company Details
 Table 102. Cellectis Business Overview
 Table 103. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 104. Cellectis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 105. Cellectis Recent Development
 Table 106. Allogene Therapeutics Company Details
 Table 107. Allogene Therapeutics Business Overview
 Table 108. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 109. Allogene Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 110. Allogene Therapeutics Recent Development
 Table 111. Celyad Company Details
 Table 112. Celyad Business Overview
 Table 113. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Product
 Table 114. Celyad Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025) & (US$ Million)
 Table 115. Celyad Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Picture
 Figure 2. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. CD19-targeted Features
 Figure 5. BCMA-targeted Features
 Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Lymphoma Case Studies
 Figure 9. Multiple Myeloma Case Studies
 Figure 10. Chimeric Antigen Receptor (CAR) T-Cell Therapy Report Years Considered
 Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 14. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Players in 2024
 Figure 15. Global Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Therapy as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in 2024
 Figure 17. North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Country (2020-2031)
 Figure 19. United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Country (2020-2031)
 Figure 23. Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Region (2020-2031)
 Figure 31. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Country (2020-2031)
 Figure 39. Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Country (2020-2031)
 Figure 43. Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Novartis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 47. Gilead Sciences Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 49. J & J Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 50. JW Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 51. FOSUNKite Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 52. CARsgen Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 53. Autolus Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 54. Sorrento Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 55. Mustang Bio Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 56. Bluebird Bio Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 57. Cellectis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 58. Allogene Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 59. Celyad Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Therapy Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2024
CAR T Cell Therapy Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CAR T Cell Immunotherapies for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CAR T Cellular Immunotherapy Drug Market Research Report 2024
CAR T Therapy in Haematological Malignancy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024
TCR Based Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
T Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global T Cell Immunotherapy Market Research Report 2025
Global Cellular and Gene Therapy Product Market Research Report 2025
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Immunotherapy Market
Global CAR T Cell Development Service Market Research Report 2024
Graft Versus Host Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gamma Delta T Cell Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CAR T Cell Service Market Research Report 2024
Global CAR T Cell Therapy Market Research Report 2025
Thymus Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions